Selective reduction of 6-O-sulfation in heparan sulfate from transformed mammary epithelial cells

European Journal of Biochemistry

Volumn 252, Issue 3, 1998, Pages 576-582

  Safaiyan, Fariba ^a   Lindahl, Ulf ^a   Salmivirta, Markku ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Heparan sulfate; Proteoglycan; Structure; Transformation

Indexed keywords

HEPARAN SULFATE; TESTOSTERONE;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REDUCTION; SULFATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; DISACCHARIDES; EPITHELIAL CELLS; FEMALE; HEPARITIN SULFATE; MAMMARY GLANDS, ANIMAL; MEMBRANE GLYCOPROTEINS; MICE; MODELS, BIOLOGICAL; PROTEOGLYCANS; RECOMBINANT PROTEINS; SULFATES; SULFUR RADIOISOTOPES; SYNDECANS; TESTOSTERONE; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0032521626     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1998.2520576.x     Document Type: Article

References (40)

1. Gallagher, J. T. (1989) The extended family of proteoglycans: social residents of the pericellular zone, Curr. Opin. Cell Biol. 1, 1201-1218.
2. Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M. T., Spring, J., Gallo, R. L. & Lose, E. J. (1992) Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans, Annu. Rev. Cell Biol. 8, 365-393.
3. David, G. (1993) Integral membrane heparan sulfate proteoglycans, FASEB J. 7, 1023-1030.
4. Kjellén, L. & Lindahl, U. (1991) Proteoglycans: structures and interactions, Annu. Rev. Biochem. 60, 443-475.
5. Salmivirta, M. & Jalkanen, M. (1995) Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules, Experientia (Basel) 51, 863-872.
6. Salmivirta, M., Lidholt, K. & Lindahl, U. (1996) Heparan sulfate-a piece of information, FASEB J. 10, 1270-1279.
7. Gallagher, J. T. (1994) Heparan sulphates as membrane receptors for the fibroblast-growth factors, Eur. J. Clin. Chem. Clin. Biochem. 32, 239-247.
8. Lyon, M., Deakin, J. A., Mizuno, K., Nakamura, T. & Gallagher, J. T. (1994) Interaction of hepatocyte-growth factor with heparan sulfate: Elucidation of the major heparan sulfate structural determinants, J. Biol. Chem. 269, 11216-11223.
9. Ashikari, S., Habuchi, H. & Kimata, K. (1995) Characterization of heparan sulfate oligosaccharides that bind to hepatocyte-growth factor, J. Biol. Chem. 270, 29586-29593.
10. Feyzi, E., Lustig, F., Fager, G., Spillmann, D., Lindahl, U. & Salmivirta, M. (1997) Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain, J. Biol. Chem. 272, 5518-5524.
11. Taipale, J. & Keski-Oja, J. (1997) Growth factors in the extracellular matrix, FASEB J. 11, 51-59.
12. Saunders, S. & Bernfield, M. (1988) Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix, J. Cell Biol. 106, 423-430.
13. Sanderson, R., Sneed, T., Young, L., Sullivan, G. & Lander, A. (1992) Adhesion of B lymphoid (MPC-11) cells to type 1 collagen is mediated by the integral membrane proteoglycan, syndecan, J. Immunol. 148, 3902-3911.
14. Maccarana, M., Sakura, Y., Tawada, A., Yoshida, K. & Lindahl, U. (1996) Domain structure of heparan sulfates from bovine organs, J. Biol. Chem. 271, 17804-17810.
15. Bourin, M. C. & Lindahl, U. (1993) Glycosaminoglycans and the regulation of blood coagulation, Biochem. J. 289, 313-330.
16. Turnbull, J. E., Fernig, D. G., Ke, Y., Wilkinson, M. C. & Gallagher, J. T. (1992) Identification of the basic fibroblast-growth factor binding sequence in fibroblast heparan sulfate, J. Biol. Chem. 267, 10337-10341.
17. Habuchi, H., Suzuki, S., Saito, T., Tamura, T., Harada, T., Yoshida, K. & Kimata, K. (1992) Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast-growth factor, Biochem. J. 285, 805-813.
18. Maccarana, M., Casu, B. & Lindahl, U. (1993) Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast-growth factor, J. Biol. Chem. 268, 23898-23905.
19. Walker, A. & Gallagher, J. T. (1996) Structural domains of heparan sulphate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEPII), Biochem. J. 317, 871-877.
20. Iozzo, R. V. (1985) Proteoglycans: structure, function and role in neoplasia, Lab. Invest. 53, 373-396.
21. Winterbourne, D. J. & Mora, P. T. (1981) Cells selected for high tumorigenicity or transformed by simian virus 40 synthesize heparan sulfate with reduced degree of sulfation, J. Biol. Chem. 256, 4310-4320.
22. Pejler, G. & David, G. (1987) Basement-membrane heparan sulphate with high affinity for antithrombin synthesized by normal and transformed mouse mammary epithelial cells, Biochem. J. 248, 69-77.
23. Nakanishi, H., Oguri, K., Yoshida, K., Itano, N., Takenaga, K., Kazama, T., Yoshida, A. & Okayama, M. (1992) Structural differences between heparan sulphates of proteoglycan involved in the formation of basement membranes in vivo by Lewis-lung-carcinoma-derived cells with different metastatic potentials, Biochem. J. 288, 215-224.
24. Jayson, G. C., Lyon, M., Paraskeva, C., Turnbull, J. E., Deakin, J. A. & Gallagher, J. T. (1998) Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro, J. Biol. Chem. 273, 51-57.
25. Nakajima, M., Irimura, T., Di Ferrante, N. & Nicolson, G. L. (1984) Metastatic melanoma cell heparanase: characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase, J. Biol. Chem. 259, 2283-2290.
26. Inki, P., Joensuu, H., Grénman, R., Klemi, P. & Jalkanen, M. (1994) Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck, Br. J. Cancer 70, 319-323.
27. Iozzo, R. V. & Cohen, I. (1993) Altered proteoglycan gene expression and the tumor stroma, Experientia (Basel) 49, 447-455.
28. Cohen, I. R., Murdoch, A. D., Naso, M. F., Marchetti, D., Berd, D. & Iozzo, R. V. (1994) Abnormal expression of perlecan proteoglycan in metastatic melanomas, Cancer Res. 54, 5771-5774.
29. Leppä, S., Härkönen, P. & Jalkanen, M. (1991) Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells, Cell Regul. 2, 1-11.
30. Yates, J. & King, R. J. B. (1981) Correlation of growth properties and morphology with hormone responsiveness of mammary tumor cells in culture, Cancer Res. 41, 258-262.
31. Leppä, S., Mali, M., Miettinen, H. M. & Jalkanen, M. (1992) Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells, Proc. Natl Acad. Sci. USA 89, 932-936.
32. Shively, J. E. & Conrad, H. E. (1976) Formation of anhydrosugars in chemical depolymerization of heparin, Biochemistry 15, 3932-3942.
33. Guo, Y. & Conrad, H. E. (1989) The disaccharide composition of heparins and heparan sulfates, Anal. Biochem. 176, 96-104.
34. Bienkowski, M. J. & Conrad, H. E. (1985) Structural characterization of the oligosaccharides formed by depolymerization of heparin with nitrous acid, J. Biol. Chem. 260, 356-365.
35. Parthasarathy, N., Goldberg, I. J., Sivaram, P., Mulloy, B., Flory, D. M. & Wagner, W. D. (1994) Oligosaccharide sequences of endothelial cell surface heparan sulfate with affinity for lipoprotein lipase, J. Biol. Chem. 269, 22391-22396.
36. Feyzi, E., Trybala, E., Bergström, T., Lindahl, U. & Spillmann, D. (1997) Structural requirement of heparan sulfate for interaction with Herpes Simplex virus type 1 virions and isolated glycoprotein C. J. Biol. Chem. 272, 24850-24857.
37. Guimond, S., Maccarana, M., Olwin, B. B., Lindahl, U. & Rapraeger, A. C. (1993) Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4, J. Biol. Chem. 268, 23906-23914.
38. Sundberg, C., Branting, M., Gerdin, B. & Rubin, K. (1997) Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/ BB to stromal cells, Am. J. Pathol. 151, 479-492.
39. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat. Med. 1, 27-31.
40. Rosen, E. M. & Goldberg, I. D. (1997) Regulation of angiogenesis by scatter factor, Experientia (Basel) 79, 193-208.